Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
2.000
+0.070 (3.63%)
At close: Aug 19, 2026, 4:00 PM EDT
1.990
-0.010 (-0.50%)
After-hours: Aug 19, 2026, 7:35 PM EDT
Karyopharm Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 54.98 | 60.54 | 62.48 | 52.23 | 135.19 | 190.46 |
Short-Term Investments | 10.13 | 3.2 | 46.24 | 139.21 | 142.78 | 38.16 |
Cash & Short-Term Investments | 65.11 | 63.74 | 108.71 | 191.44 | 277.97 | 228.62 |
Cash Growth | 25.94% | -41.36% | -43.21% | -31.13% | 21.59% | -8.28% |
Receivables | 29.87 | 26.18 | 30.77 | 27.96 | 54.89 | 23.9 |
Inventory | 3.99 | 4.04 | 4.74 | 3.04 | 4.22 | 4.11 |
Prepaid Expenses | 7.41 | 9.19 | 12.25 | 10.81 | 12.02 | 12.64 |
Restricted Cash | - | - | - | 0.66 | 1.06 | 6.35 |
Total Current Assets | 106.38 | 103.15 | 156.46 | 233.92 | 350.16 | 275.61 |
Property, Plant & Equipment | 4.35 | 4.65 | 6.28 | 4.88 | 7.38 | 9.56 |
Long-Term Accounts Receivable | - | - | - | - | - | 19.51 |
Other Long-Term Assets | 0.59 | 0.62 | 1.67 | 1.64 | 0.63 | 0.64 |
Total Assets | 111.32 | 108.42 | 164.42 | 240.44 | 358.17 | 305.31 |
Accounts Payable | 7.66 | 4 | 5.11 | 3.12 | 2.77 | 1.6 |
Accrued Expenses | 78.8 | 64.5 | 60.65 | 61.39 | 58.42 | 69.12 |
Short-Term Debt | - | - | 24.43 | - | - | - |
Current Portion of Long-Term Debt | 40.31 | 21.01 | - | - | - | - |
Current Portion of Leases | 1.07 | 0.97 | 0.44 | 3.31 | 2.87 | 2.32 |
Other Current Liabilities | 6.39 | 1.58 | 1.64 | 1.65 | 1.85 | 0.68 |
Total Current Liabilities | 134.23 | 92.06 | 92.26 | 69.48 | 65.91 | 73.72 |
Long-Term Debt | 281.97 | 278.22 | 236.45 | 303.4 | 302.82 | 302.29 |
Long-Term Leases | 5.18 | 5.74 | 6.71 | 2.79 | 6.1 | 8.97 |
Other Long-Term Liabilities | 20.1 | 25.32 | 15.01 | 0.98 | - | - |
Total Liabilities | 441.49 | 401.34 | 350.44 | 376.64 | 374.83 | 384.98 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 1,519 | 1,466 | 1,378 | 1,351 | 1,328 | 1,099 |
Retained Earnings | -1,849 | -1,759 | -1,563 | -1,487 | -1,344 | -1,179 |
Comprehensive Income & Other | 0.04 | 0.07 | -0.36 | -0.16 | -0.64 | 0.19 |
Shareholders' Equity | -330.17 | -292.93 | -186.02 | -136.21 | -16.66 | -79.67 |
Total Liabilities & Equity | 111.32 | 108.42 | 164.42 | 240.44 | 358.17 | 305.31 |
Total Debt | 328.53 | 305.95 | 268.02 | 309.5 | 311.79 | 313.58 |
Net Cash (Debt) | -263.43 | -242.2 | -159.31 | -118.05 | -33.83 | -84.96 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -13.57 | -22.15 | -18.84 | -15.50 | -6.20 | -16.94 |
Filing Date Shares Outstanding | 22.68 | 18.34 | 8.42 | 7.67 | 7.56 | 5.28 |
Total Common Shares Outstanding | 22.68 | 18.31 | 8.41 | 7.66 | 7.55 | 5.05 |
Working Capital | -27.86 | 11.09 | 64.2 | 164.44 | 284.25 | 201.89 |
Book Value Per Share | -14.56 | -16.00 | -22.11 | -17.78 | -2.21 | -15.78 |
Tangible Book Value | -330.17 | -292.93 | -186.02 | -136.21 | -16.66 | -79.67 |
Tangible Book Value Per Share | -14.56 | -16.00 | -22.11 | -17.78 | -2.21 | -15.78 |
Machinery | - | 2.21 | 2.21 | 2.29 | 2.33 | 2.25 |
Leasehold Improvements | - | 3.4 | 4.88 | 4.88 | 5.45 | 5.45 |